0001013606-19-000167.txt : 20191001 0001013606-19-000167.hdr.sgml : 20191001 20191001162934 ACCESSION NUMBER: 0001013606-19-000167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191001 DATE AS OF CHANGE: 20191001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lemaitre Dan CENTRAL INDEX KEY: 0001478479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 191129457 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495984741 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 4 1 wf-form4_156996175134943.xml FORM 4 X0306 4 2019-09-30 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0001478479 Lemaitre Dan 2 MUSICK IRVINE CA 92618 1 0 0 0 Option to Purchase 43.8 2019-09-30 4 D 0 5000 D 2010-12-10 2019-12-10 Common Stock 5000.0 0 D Option to Purchase 43.6 2019-09-30 4 D 0 2000 D 2011-05-20 2020-05-20 Common Stock 2000.0 0 D Option to Purchase 82.6 2019-09-30 4 D 0 2000 D 2012-05-25 2021-05-25 Common Stock 2000.0 0 D Option to Purchase 4.71 2019-09-30 4 A 0 2834 A 2020-09-10 2026-09-10 Common Stock 2834.0 2834 D Options vested equally over four years. The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 5,000 shares of common stock granted to the reporting person on December 10, 2009, (ii) an option for 2,000 shares of common stock granted to the reporting person on May 20, 2010, and (iii) an option for 2,000 shares of common stock granted to the reporting person on May 25, 2011. In exchange, the reporting person received a new stock option, for 2,834 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019. 100% of the options vested on May 20, 2011. 100% of the options vested on May 25, 2012. The options vest in three equal annual installments over a three-year period commencing on September 10, 2019. Dan Lemaitre by Timothy N. Brady, Attorney-in-Fact for Reporting Person 2019-10-01